caffeine has been researched along with Breast Cancer in 78 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Findings from this meta-analysis suggested that coffee/caffeine might be weakly associated with breast cancer risk for postmenopausal women, and the association for BRCA1 mutation carriers deserves further investigation." | 8.89 | Coffee and caffeine intake and breast cancer risk: an updated dose-response meta-analysis of 37 published studies. ( Jiang, W; Jiang, X; Wu, Y, 2013) |
| "The potential association of breast cancer and caffeine intake was examined using international aggregate data." | 8.77 | Caffeine ingestion and breast cancer. A negative correlation. ( Phelps, CE; Phelps, HM, 1988) |
| "We investigated the association of coffee and caffeine with breast cancer (BCa) risk, overall and by ER/PR status." | 8.12 | Associations of coffee/caffeine consumption with postmenopausal breast cancer risk and their interactions with postmenopausal hormone use. ( Lane, DS; Lehman, A; McLaughlin, E; Neuhouser, ML; Paskett, E; Rohan, T; Snetselaar, L; Yaghjyan, L, 2022) |
| "To investigate the effects of caffeine on the proliferation and death of human breast cancer cells MCF-7 and MDA-MB-231." | 8.02 | Oxidative Stress in Caffeine Action on the Proliferation and Death of Human Breast Cancer Cells MCF-7 and MDA-MB-231. ( Cecchini, AL; Cecchini, R; Luiz, RC; Machado, KL; Marinello, PC; Silva, CFN; Silva, TNX, 2021) |
| "Research findings remain inconsistent whether caffeine consumption is associated with invasive breast cancer." | 8.02 | Caffeine intake from coffee and tea and invasive breast cancer incidence among postmenopausal women in the Women's Health Initiative. ( Freudenheim, JL; Hovey, KM; LaMonte, MJ; Mu, L; Wactawski-Wende, J; Zheng, KH; Zhu, K, 2021) |
| "The clinical and experimental findings demonstrate various anticancer properties of caffeine and caffeic acid against both ER(+) and ER(-) breast cancer that may sensitize tumor cells to tamoxifen and reduce breast cancer growth." | 7.81 | Caffeine and Caffeic Acid Inhibit Growth and Modify Estrogen Receptor and Insulin-like Growth Factor I Receptor Levels in Human Breast Cancer. ( Holly, JM; Ingvar, C; Jernström, H; Markkula, A; Perks, CM; Rose, C; Rosendahl, AH; Simonsson, M; Zeng, L, 2015) |
| "Studies of coffee and tea consumption and caffeine intake as risk factors for breast cancer are inconclusive." | 7.81 | Prospective study of breast cancer in relation to coffee, tea and caffeine in Sweden. ( Adami, HO; Löf, M; Oh, JK; Sandin, S; Ström, P; Weiderpass, E, 2015) |
| "The present findings provide a proof of principle that breast cancer myofibroblasts can be inactivated, and thereby caffeine may provide a safe and effective prevention against breast tumor growth/recurrence through inhibition of the procarcinogenic effects of active stromal fibroblasts." | 7.80 | Caffeine mediates sustained inactivation of breast cancer-associated myofibroblasts via up-regulation of tumor suppressor genes. ( Aboussekhra, A; Al-Ansari, MM, 2014) |
| "Associations between caffeine and coffee consumption and breast cancer risk are uncertain, with studies suggesting inverse and null associations." | 7.79 | High coffee intake, but not caffeine, is associated with reduced estrogen receptor negative and postmenopausal breast cancer risk with no effect modification by CYP1A2 genotype. ( Anderson, LN; Boucher, BA; Cotterchio, M; El-Sohemy, A; Lowcock, EC, 2013) |
| " The aim of this study was to compare the effect of cisplatin and inositol trisphosphate kinase inhibitor (caffeine) on human breast cancer cell line (MCF-7)." | 7.77 | Induction of apoptosis and non-apoptosis in human breast cancer cell line (MCF-7) by cisplatin and caffeine. ( Niknafs, B, 2011) |
| "Numerous mechanisms for the effects of coffee, tea and caffeine on the risk of breast cancer have been suggested." | 7.77 | No association between coffee, tea or caffeine consumption and breast cancer risk in a prospective cohort study. ( Boutron-Ruault, MC; Clavel-Chapelon, F; Fagherazzi, G; Romieu, I; Touillaud, MS, 2011) |
| "The relation between consumption of coffee, tea and caffeine and risk of breast cancer remains unsettled." | 7.74 | Coffee, tea, caffeine and risk of breast cancer: a 22-year follow-up. ( Feskanich, D; Ganmaa, D; Holmes, MD; Hunter, DJ; Li, TY; Lopez-Garcia, E; van Dam, RM; Willett, WC, 2008) |
| "Prospective data relating caffeine consumption to breast cancer risk are limited." | 7.74 | Caffeine consumption and the risk of breast cancer in a large prospective cohort of women. ( Buring, JE; Ishitani, K; Lin, J; Manson, JE; Zhang, SM, 2008) |
| "In this large cohort of Swedish women, consumption of coffee, tea, and caffeine was not associated with breast cancer incidence." | 7.71 | Coffee, tea, and caffeine consumption and breast cancer incidence in a cohort of Swedish women. ( Bergkvist, L; Holmberg, L; Michels, KB; Wolk, A, 2002) |
| "The UK National Case-Control Study Group has examined the relationship between smoking (both own smoking and passive), alcohol consumption and caffeine consumption and the risk of breast cancer." | 7.69 | Alcohol, smoking, passive smoking and caffeine in relation to breast cancer risk in young women. UK National Case-Control Study Group. ( Chilvers, CE; Deacon, JM; Smith, SJ, 1994) |
| "The association of caffeine intake and postmenopausal breast cancer incidence was assessed among 34,388 Iowa women aged 55-69 years in 1986 and followed through 1990." | 7.68 | No association between caffeine intake and postmenopausal breast cancer incidence in the Iowa Women's Health Study. ( Bisgard, KM; Folsom, AR; Kushi, LH; McKenzie, DR; Sellers, TA, 1993) |
| "The conclusion drawn in a recent paper by Minton and associates (Cancer 1983; 51:1249-1253), that caffeine and an unsaturated fat diet significantly promoted dimethylbenz(a)anthracene (DMBA)-induced breast cancer in rats, is based on fallacious statistical reasoning." | 7.67 | Statistical errors invalidate conclusions in "Caffeine and unsaturated fat diet significantly promotes DMBA-induced breast cancer in rats". ( Bernstein, L; Pike, MC, 1985) |
| "Breast cancer is the second most common malignancy among women." | 5.62 | Chimarrão consumption and prognostic factors in breast cancer: Correlation with antioxidants and blood caffeine levels. ( Bastos, FF; Bastos, VLFDC; Bastos-Neto, JDC; Calixto, MRP; Davis, RAH; de Lima, JR; Dos Santos, VL; Fagundes, TR; Madeira, TB; Nixdorf, SL; Panis, C; Rech, D; Victorino, VJ; Zanandrea, AC, 2021) |
| "Caffeine, which has been linked to benign breast disease, has an antineoplastic effect in experimental animals, whereas in tissue cultures it inhibits mitoses and induces cell differentiation." | 5.27 | Association of tumor differentiation with caffeine and coffee intake in women with breast cancer. ( Aufses, AH; Fagerstrom, R; Feinberg, M; Papatestas, AE; Pozner, J; Saevitz, J; Schwartz, I, 1986) |
| "Findings from this meta-analysis suggested that coffee/caffeine might be weakly associated with breast cancer risk for postmenopausal women, and the association for BRCA1 mutation carriers deserves further investigation." | 4.89 | Coffee and caffeine intake and breast cancer risk: an updated dose-response meta-analysis of 37 published studies. ( Jiang, W; Jiang, X; Wu, Y, 2013) |
| "The potential association of breast cancer and caffeine intake was examined using international aggregate data." | 4.77 | Caffeine ingestion and breast cancer. A negative correlation. ( Phelps, CE; Phelps, HM, 1988) |
| "We investigated the association of coffee and caffeine with breast cancer (BCa) risk, overall and by ER/PR status." | 4.12 | Associations of coffee/caffeine consumption with postmenopausal breast cancer risk and their interactions with postmenopausal hormone use. ( Lane, DS; Lehman, A; McLaughlin, E; Neuhouser, ML; Paskett, E; Rohan, T; Snetselaar, L; Yaghjyan, L, 2022) |
| "To investigate the effects of caffeine on the proliferation and death of human breast cancer cells MCF-7 and MDA-MB-231." | 4.02 | Oxidative Stress in Caffeine Action on the Proliferation and Death of Human Breast Cancer Cells MCF-7 and MDA-MB-231. ( Cecchini, AL; Cecchini, R; Luiz, RC; Machado, KL; Marinello, PC; Silva, CFN; Silva, TNX, 2021) |
| "Research findings remain inconsistent whether caffeine consumption is associated with invasive breast cancer." | 4.02 | Caffeine intake from coffee and tea and invasive breast cancer incidence among postmenopausal women in the Women's Health Initiative. ( Freudenheim, JL; Hovey, KM; LaMonte, MJ; Mu, L; Wactawski-Wende, J; Zheng, KH; Zhu, K, 2021) |
| "Coffee contains caffeine and diterpenes that were associated with decreased breast cancer risk, but results remained inconsistent." | 3.91 | Associations between Coffee Products and Breast Cancer Risk: a Case-Control study in Hong Kong Chinese Women. ( Chan, WC; Chang, LDJ; Kwok, CC; Law, SH; Lee, PMY; Tsang, KH; Tse, LA; Wang, F; Wong, CKM; Wu, C; Yeung, YC; Yu, WC, 2019) |
| "Previous studies suggest that coffee and caffeine intake may be associated with reduced breast cancer risk." | 3.88 | Associations of coffee consumption and caffeine intake with mammographic breast density. ( Colditz, G; Gasparova, A; Rosner, B; Tamimi, RM; Yaghjyan, L, 2018) |
| "Our findings suggest that coffee and/or caffeine may be associated with reduced risk of endometrial cancer but, probably, associated increased with risk of breast cancer among premenopausal or normal weight women." | 3.88 | Associations of coffee, tea and caffeine intake with risk of breast, endometrial and ovarian cancer among Canadian women. ( Arthur, R; Kirsh, VA; Rohan, TE, 2018) |
| "The clinical and experimental findings demonstrate various anticancer properties of caffeine and caffeic acid against both ER(+) and ER(-) breast cancer that may sensitize tumor cells to tamoxifen and reduce breast cancer growth." | 3.81 | Caffeine and Caffeic Acid Inhibit Growth and Modify Estrogen Receptor and Insulin-like Growth Factor I Receptor Levels in Human Breast Cancer. ( Holly, JM; Ingvar, C; Jernström, H; Markkula, A; Perks, CM; Rose, C; Rosendahl, AH; Simonsson, M; Zeng, L, 2015) |
| "Studies of coffee and tea consumption and caffeine intake as risk factors for breast cancer are inconclusive." | 3.81 | Prospective study of breast cancer in relation to coffee, tea and caffeine in Sweden. ( Adami, HO; Löf, M; Oh, JK; Sandin, S; Ström, P; Weiderpass, E, 2015) |
| "The aim of the present study was to evaluate the relative contribution of CYP1A2 isoforms (-3860 G/A, -2467T/delT and -163C/A) in control subjects and breast cancer patients to the metabolism of caffeine in human liver." | 3.81 | Breast Cancer Association with CYP1A2 Activity and Gene Polymorphisms--a Preliminary Case-control Study in Tunisia. ( Arij, M; Imene, A; Maurice, AJ; Saad, S; Sofia, P, 2015) |
| "The present findings provide a proof of principle that breast cancer myofibroblasts can be inactivated, and thereby caffeine may provide a safe and effective prevention against breast tumor growth/recurrence through inhibition of the procarcinogenic effects of active stromal fibroblasts." | 3.80 | Caffeine mediates sustained inactivation of breast cancer-associated myofibroblasts via up-regulation of tumor suppressor genes. ( Aboussekhra, A; Al-Ansari, MM, 2014) |
| "Associations between caffeine and coffee consumption and breast cancer risk are uncertain, with studies suggesting inverse and null associations." | 3.79 | High coffee intake, but not caffeine, is associated with reduced estrogen receptor negative and postmenopausal breast cancer risk with no effect modification by CYP1A2 genotype. ( Anderson, LN; Boucher, BA; Cotterchio, M; El-Sohemy, A; Lowcock, EC, 2013) |
| "Capsaicin treatment was previously reported to reduce the sensitivity of breast cancer cells, but not normal MCF10A cells, to apoptosis." | 3.78 | Role of autophagy in chemoresistance: regulation of the ATM-mediated DNA-damage signaling pathway through activation of DNA-PKcs and PARP-1. ( Ahn, SG; Jung, SH; Lee, BH; Oh, SH; Yoon, JH, 2012) |
| "Our findings suggest that coffee, black tea, and caffeine consumption before breast cancer diagnosis do not influence breast cancer-specific and overall survival." | 3.78 | Coffee and black tea consumption and breast cancer mortality in a cohort of Swedish women. ( Bergkvist, L; Harris, HR; Wolk, A, 2012) |
| " The aim of this study was to compare the effect of cisplatin and inositol trisphosphate kinase inhibitor (caffeine) on human breast cancer cell line (MCF-7)." | 3.77 | Induction of apoptosis and non-apoptosis in human breast cancer cell line (MCF-7) by cisplatin and caffeine. ( Niknafs, B, 2011) |
| "Numerous mechanisms for the effects of coffee, tea and caffeine on the risk of breast cancer have been suggested." | 3.77 | No association between coffee, tea or caffeine consumption and breast cancer risk in a prospective cohort study. ( Boutron-Ruault, MC; Clavel-Chapelon, F; Fagherazzi, G; Romieu, I; Touillaud, MS, 2011) |
| "Our findings suggest that intakes of tea, coffee, and caffeine are not associated with the risk of breast cancer among African-American women." | 3.76 | Tea and coffee intake in relation to risk of breast cancer in the Black Women's Health Study. ( Adams-Campbell, LL; Boggs, DA; Palmer, JR; Rosenberg, L; Spiegelman, D; Stampfer, MJ, 2010) |
| "Prospective data relating caffeine consumption to breast cancer risk are limited." | 3.74 | Caffeine consumption and the risk of breast cancer in a large prospective cohort of women. ( Buring, JE; Ishitani, K; Lin, J; Manson, JE; Zhang, SM, 2008) |
| "The relation between consumption of coffee, tea and caffeine and risk of breast cancer remains unsettled." | 3.74 | Coffee, tea, caffeine and risk of breast cancer: a 22-year follow-up. ( Feskanich, D; Ganmaa, D; Holmes, MD; Hunter, DJ; Li, TY; Lopez-Garcia, E; van Dam, RM; Willett, WC, 2008) |
| "Caffeine has been suggested as a possible risk factor for breast cancer, potentially through its effect of facilitating the development of benign breast disease." | 3.73 | Consumption of coffee, but not black tea, is associated with decreased risk of premenopausal breast cancer. ( Baker, JA; Beehler, GP; Jayaprakash, V; McCann, SE; Moysich, KB; Sawant, AC, 2006) |
| "To describe the baseline healthy lifestyle behaviors (dietary, calcium, vitamin D, caffeine and alcohol intake, smoking history, and physical activity) of postmenopausal breast cancer survivors (BCS); and to identify any relationship of healthy lifestyle behaviors with bone mineral density (BMD) at the forearm, total hip and spine, L1-L4." | 3.73 | Health behaviors in breast cancer survivors experiencing bone loss. ( Gross, GJ; Lindsey, AM; Ott, CD; Twiss, JJ; Waltman, NL, 2006) |
| "In this large cohort of Swedish women, consumption of coffee, tea, and caffeine was not associated with breast cancer incidence." | 3.71 | Coffee, tea, and caffeine consumption and breast cancer incidence in a cohort of Swedish women. ( Bergkvist, L; Holmberg, L; Michels, KB; Wolk, A, 2002) |
| "Caffeine intake has been proposed to influence breast cancer risk." | 3.70 | Association of coffee, green tea, and caffeine intakes with serum concentrations of estradiol and sex hormone-binding globulin in premenopausal Japanese women. ( Kabuto, M; Nagata, C; Shimizu, H, 1998) |
| "The expression of common fragile sites induced by aphidicolin and caffeine was evaluated on prometaphase obtained from the peripheral blood lymphocytes of 35 women with breast cancer, their 35 clinically healthy female family members, and 20 sex- and age-matched normal controls." | 3.70 | Common fragile site expression and genetic predisposition to breast cancer. ( Ceçener, G; Duman, H; Egeli, U; Kizil, A; Taşdelen, I; Tunca, B, 1998) |
| "The UK National Case-Control Study Group has examined the relationship between smoking (both own smoking and passive), alcohol consumption and caffeine consumption and the risk of breast cancer." | 3.69 | Alcohol, smoking, passive smoking and caffeine in relation to breast cancer risk in young women. UK National Case-Control Study Group. ( Chilvers, CE; Deacon, JM; Smith, SJ, 1994) |
| "A study of MCF-7 human breast cancer cells was undertaken to ascertain the degree of apoptosis induction by paclitaxel and if the induction of apoptosis could be enhanced by caffeine." | 3.69 | Paclitaxel-induced apoptosis in MCF-7 breast-cancer cells. ( Christensen, C; Deppe, G; Lawrence, WD; Ruan, H; Saunders, DE; Wappler, NL, 1997) |
| "The association of caffeine intake and postmenopausal breast cancer incidence was assessed among 34,388 Iowa women aged 55-69 years in 1986 and followed through 1990." | 3.68 | No association between caffeine intake and postmenopausal breast cancer incidence in the Iowa Women's Health Study. ( Bisgard, KM; Folsom, AR; Kushi, LH; McKenzie, DR; Sellers, TA, 1993) |
| "The conclusion drawn in a recent paper by Minton and associates (Cancer 1983; 51:1249-1253), that caffeine and an unsaturated fat diet significantly promoted dimethylbenz(a)anthracene (DMBA)-induced breast cancer in rats, is based on fallacious statistical reasoning." | 3.67 | Statistical errors invalidate conclusions in "Caffeine and unsaturated fat diet significantly promotes DMBA-induced breast cancer in rats". ( Bernstein, L; Pike, MC, 1985) |
| "Dietary polyphenols may protect against breast cancer." | 2.90 | Metabolic Profiling of Dietary Polyphenols and Methylxanthines in Normal and Malignant Mammary Tissues from Breast Cancer Patients. ( Abellán, B; Ávila-Gálvez, MÁ; Espín, JC; García-Villalba, R; González-Sarrías, A; Martínez-Díaz, F; Monedero-Saiz, T; Ocaña-Castillo, B; Torrecillas-Sánchez, A, 2019) |
| "Among the 48 human ABC proteins, the breast cancer resistance protein (BCRP/ABCG2) has been described as a pivotal player in cancer resistance." | 2.82 | Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators. ( Delabio, LC; Dutra, JP; Hembecker, M; Kita, DH; Moure, VR; Pereira, GDS; Scheiffer, G; Valdameri, G; Zattoni, IF, 2022) |
| "Coffee is inversely associated with breast cancer risk in postmenopausal women and in women carrying a BRCA1 mutation." | 2.72 | Coffee consumption and breast cancer risk: a narrative review in the general population and in different subtypes of breast cancer. ( Arbogast, P; Mathelin, C; Nehlig, A; Reix, N, 2021) |
| "Breast cancer is the second most common malignancy among women." | 1.62 | Chimarrão consumption and prognostic factors in breast cancer: Correlation with antioxidants and blood caffeine levels. ( Bastos, FF; Bastos, VLFDC; Bastos-Neto, JDC; Calixto, MRP; Davis, RAH; de Lima, JR; Dos Santos, VL; Fagundes, TR; Madeira, TB; Nixdorf, SL; Panis, C; Rech, D; Victorino, VJ; Zanandrea, AC, 2021) |
| "22,652 incident cancers occurred during 10." | 1.51 | Association between tea consumption and risk of cancer: a prospective cohort study of 0.5 million Chinese adults. ( Bian, Z; Chen, F; Chen, J; Chen, Y; Chen, Z; Guo, Y; Li, L; Li, X; Lv, J; Qiu, Z; Shen, Z; Wei, Y; Yang, L; Yu, C; Zhang, H, 2019) |
| "Colorectal and breast cancer cell lineages, HT-29 and MCF-7 cells, respectively, were exposed to different guaraná concentrations (0." | 1.46 | Guaraná, a Highly Caffeinated Food, Presents in vitro Antitumor Activity in Colorectal and Breast Cancer Cell Lines by Inhibiting AKT/mTOR/S6K and MAPKs Pathways. ( Assmann, CE; Azzolin, VF; Cadoná, FC; Cubillos-Rojas, M; da Cruz, IBM; Machado, AK; Ribeiro, EE; Rosa, JL; Sánchez-Tena, S; Schneider, T, 2017) |
| "We have shown here that breast cancer cells and IL-6 persistently activate breast stromal fibroblasts through the stimulation of the positive IL-6/STAT3/NF-κB feedback loop." | 1.43 | The inflammatory/cancer-related IL-6/STAT3/NF-κB positive feedback loop includes AUF1 and maintains the active state of breast myofibroblasts. ( Aboussekhra, A; Al-Ansari, MM; Al-Harbi, B; Hendrayani, SF; Silva, G, 2016) |
| "The CYP1A2 genotype did not affect breast cancer risk." | 1.34 | The CYP1A2 genotype modifies the association between coffee consumption and breast cancer risk among BRCA1 mutation carriers. ( Daly, M; Domchek, S; El-Sohemy, A; Ghadirian, P; Karlan, B; Kotsopoulos, J; Lynch, HT; Narod, SA; Randall, S; Snyder, C; Sun, P; Zhang, P; Zhang, S, 2007) |
| "There was no increased risk for ovarian cancer associated with possession of either the Msp1 or Ile/Val polymorphism of CYP1A1." | 1.32 | Interaction between CYP1A1 polymorphic variants and dietary exposures influencing ovarian cancer risk. ( Cramer, DW; Garner, EO; Terry, KL; Titus-Ernstoff, L; Vitonis, AF, 2003) |
| "Caffeine, which has been linked to benign breast disease, has an antineoplastic effect in experimental animals, whereas in tissue cultures it inhibits mitoses and induces cell differentiation." | 1.27 | Association of tumor differentiation with caffeine and coffee intake in women with breast cancer. ( Aufses, AH; Fagerstrom, R; Feinberg, M; Papatestas, AE; Pozner, J; Saevitz, J; Schwartz, I, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (15.38) | 18.7374 |
| 1990's | 13 (16.67) | 18.2507 |
| 2000's | 18 (23.08) | 29.6817 |
| 2010's | 27 (34.62) | 24.3611 |
| 2020's | 8 (10.26) | 2.80 |
| Authors | Studies |
|---|---|
| Qi, Q | 1 |
| Obianyo, O | 1 |
| Du, Y | 1 |
| Fu, H | 1 |
| Li, S | 1 |
| Ye, K | 1 |
| Zattoni, IF | 1 |
| Delabio, LC | 1 |
| Dutra, JP | 1 |
| Kita, DH | 1 |
| Scheiffer, G | 1 |
| Hembecker, M | 1 |
| Pereira, GDS | 1 |
| Moure, VR | 1 |
| Valdameri, G | 1 |
| Yaghjyan, L | 2 |
| McLaughlin, E | 1 |
| Lehman, A | 1 |
| Neuhouser, ML | 1 |
| Rohan, T | 1 |
| Lane, DS | 1 |
| Snetselaar, L | 1 |
| Paskett, E | 1 |
| Lee, PMY | 1 |
| Chan, WC | 1 |
| Kwok, CC | 1 |
| Wu, C | 1 |
| Law, SH | 1 |
| Tsang, KH | 1 |
| Yu, WC | 1 |
| Yeung, YC | 1 |
| Chang, LDJ | 1 |
| Wong, CKM | 1 |
| Wang, F | 1 |
| Tse, LA | 1 |
| Machado, KL | 1 |
| Marinello, PC | 1 |
| Silva, TNX | 1 |
| Silva, CFN | 1 |
| Luiz, RC | 1 |
| Cecchini, R | 1 |
| Cecchini, AL | 1 |
| McEligot, AJ | 1 |
| Poynor, V | 1 |
| Sharma, R | 1 |
| Panangadan, A | 1 |
| Calixto, MRP | 1 |
| Rech, D | 1 |
| Dos Santos, VL | 1 |
| Madeira, TB | 1 |
| Nixdorf, SL | 1 |
| Fagundes, TR | 1 |
| Davis, RAH | 1 |
| Bastos, FF | 1 |
| Bastos-Neto, JDC | 1 |
| Bastos, VLFDC | 1 |
| Zanandrea, AC | 1 |
| de Lima, JR | 1 |
| Victorino, VJ | 1 |
| Panis, C | 1 |
| Nehlig, A | 1 |
| Reix, N | 1 |
| Arbogast, P | 1 |
| Mathelin, C | 1 |
| Wang, S | 1 |
| Li, X | 2 |
| Yang, Y | 1 |
| Xie, J | 1 |
| Liu, M | 1 |
| Zhang, Y | 2 |
| Zhao, Q | 1 |
| Zheng, KH | 1 |
| Zhu, K | 1 |
| Wactawski-Wende, J | 1 |
| Freudenheim, JL | 1 |
| LaMonte, MJ | 1 |
| Hovey, KM | 1 |
| Mu, L | 1 |
| Acar, E | 1 |
| Gürdeniz, G | 1 |
| Savorani, F | 1 |
| Hansen, L | 1 |
| Olsen, A | 1 |
| Tjønneland, A | 1 |
| Dragsted, LO | 1 |
| Bro, R | 1 |
| Cadoná, FC | 1 |
| Rosa, JL | 1 |
| Schneider, T | 1 |
| Cubillos-Rojas, M | 1 |
| Sánchez-Tena, S | 1 |
| Azzolin, VF | 1 |
| Assmann, CE | 1 |
| Machado, AK | 1 |
| Ribeiro, EE | 1 |
| da Cruz, IBM | 1 |
| Colditz, G | 1 |
| Rosner, B | 1 |
| Gasparova, A | 1 |
| Tamimi, RM | 1 |
| Arthur, R | 1 |
| Kirsh, VA | 1 |
| Rohan, TE | 2 |
| Ávila-Gálvez, MÁ | 1 |
| García-Villalba, R | 1 |
| Martínez-Díaz, F | 1 |
| Ocaña-Castillo, B | 1 |
| Monedero-Saiz, T | 1 |
| Torrecillas-Sánchez, A | 1 |
| Abellán, B | 1 |
| González-Sarrías, A | 1 |
| Espín, JC | 1 |
| Yu, C | 1 |
| Guo, Y | 1 |
| Bian, Z | 1 |
| Shen, Z | 1 |
| Yang, L | 1 |
| Chen, Y | 1 |
| Wei, Y | 1 |
| Zhang, H | 1 |
| Qiu, Z | 1 |
| Chen, J | 1 |
| Chen, F | 1 |
| Chen, Z | 2 |
| Lv, J | 1 |
| Li, L | 1 |
| Lowcock, EC | 1 |
| Cotterchio, M | 1 |
| Anderson, LN | 1 |
| Boucher, BA | 1 |
| El-Sohemy, A | 2 |
| Jiang, W | 1 |
| Wu, Y | 1 |
| Jiang, X | 2 |
| Claes, K | 1 |
| Depuydt, J | 1 |
| Taylor, AM | 1 |
| Last, JI | 1 |
| Baert, A | 1 |
| Schietecatte, P | 1 |
| Vandersickel, V | 1 |
| Poppe, B | 1 |
| De Leeneer, K | 1 |
| D'Hooghe, M | 1 |
| Vral, A | 1 |
| Martins, IL | 1 |
| Miranda, JP | 1 |
| Oliveira, NG | 1 |
| Fernandes, AS | 1 |
| Gonçalves, S | 1 |
| Antunes, AM | 1 |
| Lin, JN | 1 |
| Lin, HY | 1 |
| Yang, NS | 1 |
| Li, YH | 1 |
| Lee, MR | 1 |
| Chuang, CH | 1 |
| Ho, CT | 1 |
| Kuo, SC | 1 |
| Way, TD | 1 |
| Al-Ansari, MM | 2 |
| Aboussekhra, A | 2 |
| Rosendahl, AH | 1 |
| Perks, CM | 1 |
| Zeng, L | 1 |
| Markkula, A | 1 |
| Simonsson, M | 1 |
| Rose, C | 1 |
| Ingvar, C | 1 |
| Holly, JM | 1 |
| Jernström, H | 1 |
| Oh, JK | 1 |
| Sandin, S | 1 |
| Ström, P | 1 |
| Löf, M | 1 |
| Adami, HO | 1 |
| Weiderpass, E | 1 |
| Imene, A | 1 |
| Maurice, AJ | 1 |
| Arij, M | 1 |
| Sofia, P | 1 |
| Saad, S | 1 |
| Nikitina, D | 1 |
| Vallis, K | 1 |
| Poll, A | 1 |
| Ainsworth, P | 1 |
| Narod, SA | 2 |
| Kotsopoulos, J | 3 |
| Hendrayani, SF | 1 |
| Al-Harbi, B | 1 |
| Silva, G | 1 |
| Ishitani, K | 1 |
| Lin, J | 1 |
| Manson, JE | 1 |
| Buring, JE | 1 |
| Zhang, SM | 1 |
| Tang, N | 1 |
| Zhou, B | 1 |
| Wang, B | 1 |
| Yu, R | 1 |
| Eliassen, AH | 1 |
| Missmer, SA | 1 |
| Hankinson, SE | 1 |
| Tworoger, SS | 1 |
| Boggs, DA | 1 |
| Palmer, JR | 1 |
| Stampfer, MJ | 1 |
| Spiegelman, D | 1 |
| Adams-Campbell, LL | 2 |
| Rosenberg, L | 2 |
| Fagherazzi, G | 1 |
| Touillaud, MS | 1 |
| Boutron-Ruault, MC | 1 |
| Clavel-Chapelon, F | 1 |
| Romieu, I | 1 |
| Gierach, GL | 1 |
| Freedman, ND | 1 |
| Andaya, A | 1 |
| Hollenbeck, AR | 1 |
| Park, Y | 1 |
| Schatzkin, A | 1 |
| Brinton, LA | 2 |
| Yoon, JH | 1 |
| Ahn, SG | 1 |
| Lee, BH | 1 |
| Jung, SH | 1 |
| Oh, SH | 1 |
| Niknafs, B | 1 |
| Johnson, JK | 1 |
| Waddell, N | 1 |
| Chenevix-Trench, G | 1 |
| Mitchell, A | 1 |
| McCrea, P | 1 |
| Inglis, K | 1 |
| Porter, G | 1 |
| Harris, HR | 1 |
| Bergkvist, L | 2 |
| Wolk, A | 2 |
| Terry, KL | 1 |
| Titus-Ernstoff, L | 1 |
| Garner, EO | 1 |
| Vitonis, AF | 1 |
| Cramer, DW | 1 |
| Essmann, F | 1 |
| Engels, IH | 1 |
| Totzke, G | 1 |
| Schulze-Osthoff, K | 2 |
| Jänicke, RU | 1 |
| Pobst, LJ | 1 |
| Ames, MM | 1 |
| Wendt, J | 1 |
| Radetzki, S | 1 |
| von Haefen, C | 1 |
| Hemmati, PG | 1 |
| Güner, D | 1 |
| Dörken, B | 1 |
| Daniel, PT | 1 |
| Baker, JA | 1 |
| Beehler, GP | 1 |
| Sawant, AC | 1 |
| Jayaprakash, V | 1 |
| McCann, SE | 1 |
| Moysich, KB | 1 |
| Natarajan, TG | 1 |
| Ganesan, N | 1 |
| Carter-Nolan, P | 1 |
| Tucker, CA | 1 |
| Shields, PG | 1 |
| Twiss, JJ | 1 |
| Gross, GJ | 1 |
| Waltman, NL | 1 |
| Ott, CD | 1 |
| Lindsey, AM | 1 |
| Ghadirian, P | 1 |
| Lynch, HT | 1 |
| Snyder, C | 1 |
| Daly, M | 1 |
| Domchek, S | 1 |
| Randall, S | 1 |
| Karlan, B | 1 |
| Zhang, P | 1 |
| Zhang, S | 1 |
| Sun, P | 1 |
| Ganmaa, D | 1 |
| Willett, WC | 1 |
| Li, TY | 1 |
| Feskanich, D | 1 |
| van Dam, RM | 1 |
| Lopez-Garcia, E | 1 |
| Hunter, DJ | 1 |
| Holmes, MD | 1 |
| Li, Z | 1 |
| Liu, W | 1 |
| Mo, B | 1 |
| Hu, C | 1 |
| Liu, H | 1 |
| Qi, H | 1 |
| Wang, X | 1 |
| Xu, J | 1 |
| Barber, R | 1 |
| Goka, TJ | 1 |
| Butcher, RW | 1 |
| Brooks, PG | 1 |
| Welsch, CW | 2 |
| el-Bayoumy, K | 1 |
| Smith, SJ | 1 |
| Deacon, JM | 1 |
| Chilvers, CE | 1 |
| Folsom, AR | 1 |
| McKenzie, DR | 1 |
| Bisgard, KM | 1 |
| Kushi, LH | 1 |
| Sellers, TA | 1 |
| Monnin, S | 1 |
| Schiller, MR | 1 |
| Sachs, L | 1 |
| Smith, AM | 1 |
| Vineis, P | 1 |
| Saunders, DE | 1 |
| Lawrence, WD | 1 |
| Christensen, C | 1 |
| Wappler, NL | 1 |
| Ruan, H | 1 |
| Deppe, G | 1 |
| Nagata, C | 1 |
| Kabuto, M | 1 |
| Shimizu, H | 1 |
| Tavani, A | 1 |
| Pregnolato, A | 1 |
| La Vecchia, C | 1 |
| Favero, A | 1 |
| Franceschi, S | 1 |
| Ceçener, G | 1 |
| Egeli, U | 1 |
| Taşdelen, I | 1 |
| Tunca, B | 1 |
| Duman, H | 1 |
| Kizil, A | 1 |
| Valenzuela, MT | 1 |
| Mateos, S | 1 |
| Ruiz de Almodóvar, JM | 1 |
| McMillan, TJ | 1 |
| Lim, LY | 1 |
| Daly, JW | 1 |
| Li, AH | 1 |
| Jacobson, KA | 1 |
| Roberge, M | 1 |
| Matsuoka, M | 1 |
| Igisu, H | 1 |
| Michels, KB | 1 |
| Holmberg, L | 1 |
| Jha, MN | 1 |
| Bamburg, JR | 1 |
| Bernstein, BW | 1 |
| Bedford, JS | 1 |
| McLaughlin, CC | 1 |
| Mahoney, MC | 1 |
| Nasca, PC | 1 |
| Metzger, BB | 1 |
| Baptiste, MS | 1 |
| Field, NA | 1 |
| Wolfrom, D | 1 |
| Lubin, F | 2 |
| Ron, E | 2 |
| Schairer, C | 1 |
| Hoover, RN | 1 |
| Phelps, HM | 1 |
| Phelps, CE | 1 |
| McMichael, AJ | 1 |
| Jackson, VP | 1 |
| Lex, AM | 1 |
| Smith, DJ | 1 |
| Cerrato, PL | 1 |
| Pozner, J | 1 |
| Papatestas, AE | 1 |
| Fagerstrom, R | 1 |
| Schwartz, I | 1 |
| Saevitz, J | 1 |
| Feinberg, M | 1 |
| Aufses, AH | 1 |
| Wax, Y | 1 |
| Modan, B | 1 |
| Pozniak, PC | 1 |
| Pike, MC | 1 |
| Bernstein, L | 1 |
| Miller, DR | 1 |
| Helmrich, SP | 1 |
| Kaufman, DW | 1 |
| Schottenfeld, D | 1 |
| Stolley, PD | 1 |
| Shapiro, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Post-operative Analgesia in Elective, Soft-tissue Hand Surgery: A Randomized, Double Blind Comparison of Acetaminophen/Ibuprofen Versus Acetaminophen/Hydrocodone[NCT02029235] | Phase 4 | 72 participants (Actual) | Interventional | 2015-02-10 | Terminated (stopped due to Early termination due to slower than anticipated recruitment.) | ||
| Prevention of Osteoporosis in Breast Cancer Survivors[NCT00567606] | 249 participants (Actual) | Interventional | 2002-04-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
"Subjects asked to fill out a patient diary recording their pain intensity level (on 100mm Visual Analog Scale) prior to taking study medication every 4 hours.~The daily average pain intensity levels are reported as a score on a scale of 0-100, with higher score meaning worse outcome.~The daily average pain levels were assessed daily for 1 week post-operatively, then compared between the 2 groups using a two-group Student's t-test." (NCT02029235)
Timeframe: 1 week post-operatively
| Intervention | score on a scale (0-100, higher = worse) (Mean) | ||||||
|---|---|---|---|---|---|---|---|
| Daily average pain intensity level on PostOp Day 1 | Daily average pain intensity level on PostOp Day 2 | Daily average pain intensity level on PostOp Day 3 | Daily average pain intensity levelon PostOp Day 4 | Daily average pain intensity level on PostOp Day 5 | Daily average pain intensity level on PostOp Day 6 | Daily average pain intensity level on PostOp Day 7 | |
| Acetaminophen/Hydrocodone (AH) Group | 24.07 | 30.16 | 22.11 | 18.53 | 16.61 | 13.58 | 13.00 |
| Acetaminophen/Ibuprofen (AIBU) Group | 22.17 | 22.22 | 15.67 | 13.17 | 14.03 | 13.44 | 12.67 |
"Subjects asked to fill out a patient diary recording their pain relief (on a Likert scale) one hour after taking study medication every 4 hours.~Daily average pain relief scores are reported as a score on a scale of 0-3, with higher score meaning better outcome.~The daily average pain relief scores were assessed daily for 1 week post-operatively, then compared using generalized linear mixed-effects models" (NCT02029235)
Timeframe: 1 week postoperatively
| Intervention | score on a scale (0-3, higher = better) (Mean) | ||||||
|---|---|---|---|---|---|---|---|
| Daily average pain relief on PostOp Day 1 | Daily average pain relief on PostOp Day 2 | Daily average pain relief on PostOp Day 3 | Daily average pain relief on PostOp Day 4 | Daily average pain relief on PostOp Day 5 | Daily average pain relief on PostOp Day 6 | Daily average pain relief on PostOp Day 7 | |
| Acetaminophen/Hydrocodone (AH) Group | 1.53 | 1.76 | 2.33 | 2.46 | 2.54 | 2.84 | 2.88 |
| Acetaminophen/Ibuprofen (AIBU) Group | 1.84 | 2.27 | 2.63 | 2.91 | 2.88 | 2.87 | 2.96 |
11 reviews available for caffeine and Breast Cancer
| Article | Year |
|---|---|
Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Breast Neoplasms; Dr | 2022 |
Coffee consumption and breast cancer risk: a narrative review in the general population and in different subtypes of breast cancer.
Topics: Breast Neoplasms; Caffeine; Coffee; Female; Humans; Premenopause; Risk Factors; Tamoxifen | 2021 |
Does coffee, tea and caffeine consumption reduce the risk of incident breast cancer? A systematic review and network meta-analysis.
Topics: Breast Neoplasms; Caffeine; Coffee; Female; Humans; Network Meta-Analysis; Prospective Studies; Risk | 2021 |
Coffee and caffeine intake and breast cancer risk: an updated dose-response meta-analysis of 37 published studies.
Topics: Breast Neoplasms; Caffeine; Case-Control Studies; Coffee; Dose-Response Relationship, Drug; Female; | 2013 |
Coffee consumption and risk of breast cancer: a metaanalysis.
Topics: Breast Neoplasms; Caffeine; Case-Control Studies; Central Nervous System Stimulants; Coffee; Cohort | 2009 |
Caffeine and the development of the normal and neoplastic mammary gland.
Topics: Animals; Breast Diseases; Breast Neoplasms; Caffeine; Female; Mammary Glands, Animal; Mammary Neopla | 1994 |
Evaluation of chemopreventive agents against breast cancer and proposed strategies for future clinical intervention trials.
Topics: Animals; Anticarcinogenic Agents; Arachidonic Acid; Breast Neoplasms; Caffeine; Cyclohexenes; Female | 1994 |
Caffeine and the development of normal, benign and carcinomatous human breast tissues: a relationship?
Topics: Animals; Breast; Breast Diseases; Breast Neoplasms; Caffeine; Fibrocystic Breast Disease; Humans; Ma | 1990 |
Consumption of methylxanthine-containing beverages and the risk of breast cancer.
Topics: Beverages; Breast Neoplasms; Caffeine; Case-Control Studies; Female; Humans; Xanthines | 1990 |
Caffeine ingestion and breast cancer. A negative correlation.
Topics: Breast Neoplasms; Caffeine; Dietary Fats; Humans; Regression Analysis | 1988 |
The carcinogenicity of caffeine and coffee: a review.
Topics: Breast Neoplasms; Caffeine; Coffee; Epidemiologic Methods; Female; Humans; Intestinal Neoplasms; Kin | 1985 |
2 trials available for caffeine and Breast Cancer
| Article | Year |
|---|---|
Metabolic Profiling of Dietary Polyphenols and Methylxanthines in Normal and Malignant Mammary Tissues from Breast Cancer Patients.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Breast Neoplasms, Male; Caffeine; Cell Prolife | 2019 |
A randomized, controlled trial comparing acetaminophen plus ibuprofen versus acetaminophen plus codeine plus caffeine (Tylenol 3) after outpatient breast surgery.
Topics: Acetaminophen; Adult; Ambulatory Surgical Procedures; Analgesics, Non-Narcotic; Breast Neoplasms; Ca | 2012 |
65 other studies available for caffeine and Breast Cancer
| Article | Year |
|---|---|
Blockade of Asparagine Endopeptidase Inhibits Cancer Metastasis.
Topics: Animals; Antineoplastic Agents; Breast; Breast Neoplasms; Cell Line, Tumor; Cysteine Endopeptidases; | 2017 |
Associations of coffee/caffeine consumption with postmenopausal breast cancer risk and their interactions with postmenopausal hormone use.
Topics: Breast Neoplasms; Caffeine; Female; Hormones; Humans; Postmenopause; Risk Factors | 2022 |
Associations between Coffee Products and Breast Cancer Risk: a Case-Control study in Hong Kong Chinese Women.
Topics: Adult; Aged; Aged, 80 and over; Asian People; Breast Neoplasms; Caffeine; Case-Control Studies; Coff | 2019 |
Oxidative Stress in Caffeine Action on the Proliferation and Death of Human Breast Cancer Cells MCF-7 and MDA-MB-231.
Topics: Apoptosis; Breast Neoplasms; Caffeine; Cell Line, Tumor; Cell Proliferation; Female; Humans; MCF-7 C | 2021 |
Logistic LASSO Regression for Dietary Intakes and Breast Cancer.
Topics: Alcohol Drinking; Body Mass Index; Breast Neoplasms; Caffeine; Cross-Sectional Studies; Demography; | 2020 |
Chimarrão consumption and prognostic factors in breast cancer: Correlation with antioxidants and blood caffeine levels.
Topics: Antioxidants; Breast Neoplasms; Caffeine; Female; Humans; Male; Middle Aged; Plant Leaves; Prognosis | 2021 |
Caffeine intake from coffee and tea and invasive breast cancer incidence among postmenopausal women in the Women's Health Initiative.
Topics: Aged; Breast Neoplasms; Caffeine; Carcinoma, Ductal, Breast; Coffee; Diet Surveys; Female; Follow-Up | 2021 |
Forecasting Chronic Diseases Using Data Fusion.
Topics: Acute Coronary Syndrome; Biomarkers; Breast Neoplasms; Caffeine; Chromatography, Liquid; Chronic Dis | 2017 |
Guaraná, a Highly Caffeinated Food, Presents in vitro Antitumor Activity in Colorectal and Breast Cancer Cell Lines by Inhibiting AKT/mTOR/S6K and MAPKs Pathways.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Caffeine; Cell Line, Tumor; Colorectal Neoplasm | 2017 |
Associations of coffee consumption and caffeine intake with mammographic breast density.
Topics: Adult; Aged; Aged, 80 and over; Breast Density; Breast Neoplasms; Caffeine; Coffee; Feeding Behavior | 2018 |
Associations of coffee, tea and caffeine intake with risk of breast, endometrial and ovarian cancer among Canadian women.
Topics: Adult; Aged; Breast Neoplasms; Caffeine; Canada; Coffee; Endometrial Neoplasms; Female; Humans; Life | 2018 |
Association between tea consumption and risk of cancer: a prospective cohort study of 0.5 million Chinese adults.
Topics: Adult; Aged; Alcohol Drinking; Asian People; Breast Neoplasms; Caffeine; China; Colorectal Neoplasms | 2019 |
High coffee intake, but not caffeine, is associated with reduced estrogen receptor negative and postmenopausal breast cancer risk with no effect modification by CYP1A2 genotype.
Topics: Adult; Aged; Breast Neoplasms; Caffeine; Case-Control Studies; Coffee; Cytochrome P-450 CYP1A2; Diet | 2013 |
Variant ataxia telangiectasia: clinical and molecular findings and evaluation of radiosensitive phenotypes in a patient and relatives.
Topics: Adult; Amino Acid Substitution; Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Breas | 2013 |
Synthesis and biological activity of 6-selenocaffeine: potential modulator of chemotherapeutic drugs in breast cancer cells.
Topics: Antibiotics, Antineoplastic; Antioxidants; Breast Neoplasms; Caffeine; Cell Line, Tumor; Doxorubicin | 2013 |
Chemical constituents and anticancer activity of yellow camellias against MDA-MB-231 human breast cancer cells.
Topics: Amino Acids; Antineoplastic Agents, Phytogenic; Antioxidants; Breast Neoplasms; Caffeine; Camellia; | 2013 |
Caffeine mediates sustained inactivation of breast cancer-associated myofibroblasts via up-regulation of tumor suppressor genes.
Topics: Breast Neoplasms; Caffeine; Caveolin 1; Cyclin-Dependent Kinase Inhibitor p16; Cyclin-Dependent Kina | 2014 |
Caffeine and Caffeic Acid Inhibit Growth and Modify Estrogen Receptor and Insulin-like Growth Factor I Receptor Levels in Human Breast Cancer.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Breast Neoplasms; Caffeic Acids; Caffeine; Cell C | 2015 |
Prospective study of breast cancer in relation to coffee, tea and caffeine in Sweden.
Topics: Adult; Breast Neoplasms; Caffeine; Coffee; Female; Follow-Up Studies; Humans; Middle Aged; Prospecti | 2015 |
Breast Cancer Association with CYP1A2 Activity and Gene Polymorphisms--a Preliminary Case-control Study in Tunisia.
Topics: Breast Neoplasms; Caffeine; Case-Control Studies; Cytochrome P-450 CYP1A2; Female; Genetic Predispos | 2015 |
Relationship between Caffeine and Levels of DNA Repair and Oxidative Stress in Women with and without a BRCA1 Mutation.
Topics: Adult; Aged; Breast Neoplasms; Caffeine; Case-Control Studies; Coffee; DNA Repair; Drinking Behavior | 2015 |
The inflammatory/cancer-related IL-6/STAT3/NF-κB positive feedback loop includes AUF1 and maintains the active state of breast myofibroblasts.
Topics: Breast; Breast Neoplasms; Caffeine; Cancer-Associated Fibroblasts; Cell Line; Cell Line, Tumor; Cell | 2016 |
Caffeine consumption and the risk of breast cancer in a large prospective cohort of women.
Topics: Breast Neoplasms; Caffeine; Confidence Intervals; Female; Follow-Up Studies; Humans; Incidence; Midd | 2008 |
Relationship between caffeine intake and plasma sex hormone concentrations in premenopausal and postmenopausal women.
Topics: Adult; Breast Neoplasms; Caffeine; Coffee; Diet; Female; Gonadal Steroid Hormones; Humans; Middle Ag | 2009 |
Tea and coffee intake in relation to risk of breast cancer in the Black Women's Health Study.
Topics: Adult; Aged; Black or African American; Breast Neoplasms; Caffeine; Coffee; Cohort Studies; Female; | 2010 |
No association between coffee, tea or caffeine consumption and breast cancer risk in a prospective cohort study.
Topics: Beverages; Breast Neoplasms; Caffeine; Coffee; Cohort Studies; Diet Surveys; Female; Follow-Up Studi | 2011 |
Coffee intake and breast cancer risk in the NIH-AARP diet and health study cohort.
Topics: Aged; Breast Neoplasms; Caffeine; Coffee; Cohort Studies; Diet; DNA Methylation; Female; Humans; Mid | 2012 |
Role of autophagy in chemoresistance: regulation of the ATM-mediated DNA-damage signaling pathway through activation of DNA-PKcs and PARP-1.
Topics: Apoptosis; Ataxia Telangiectasia Mutated Proteins; Autophagy; Breast Neoplasms; Caffeine; Capsaicin; | 2012 |
Induction of apoptosis and non-apoptosis in human breast cancer cell line (MCF-7) by cisplatin and caffeine.
Topics: Apoptosis; Breast Neoplasms; Caffeine; Cell Adhesion; Cell Line, Tumor; Cisplatin; DNA, Neoplasm; Fe | 2011 |
The application of nonsense-mediated mRNA decay inhibition to the identification of breast cancer susceptibility genes.
Topics: Base Sequence; Breast Neoplasms; Caffeine; Cell Line, Tumor; Family; Female; Gene Expression Profili | 2012 |
Coffee and black tea consumption and breast cancer mortality in a cohort of Swedish women.
Topics: Aged; Beverages; Breast Neoplasms; Caffeine; Coffee; Female; Humans; Incidence; Middle Aged; Prospec | 2012 |
Interaction between CYP1A1 polymorphic variants and dietary exposures influencing ovarian cancer risk.
Topics: Alleles; Breast Neoplasms; Caffeine; Confidence Intervals; Cytochrome P-450 CYP1A1; Feeding Behavior | 2003 |
Apoptosis resistance of MCF-7 breast carcinoma cells to ionizing radiation is independent of p53 and cell cycle control but caused by the lack of caspase-3 and a caffeine-inhibitable event.
Topics: Apoptosis; Breast Neoplasms; Caffeine; Caspase 3; Caspase 9; Caspases; Cell Cycle; Cell Line, Tumor; | 2004 |
CYP1A1 activation of aminoflavone leads to DNA damage in human tumor cell lines.
Topics: Androstadienes; Ataxia Telangiectasia Mutated Proteins; Breast Neoplasms; Caffeine; Cell Cycle Prote | 2006 |
Induction of p21CIP/WAF-1 and G2 arrest by ionizing irradiation impedes caspase-3-mediated apoptosis in human carcinoma cells.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Caffeine; Carcinoma; Caspase 3; Caspases; Cyclin | 2006 |
Consumption of coffee, but not black tea, is associated with decreased risk of premenopausal breast cancer.
Topics: Adult; Aged; Body Mass Index; Breast Neoplasms; Caffeine; Case-Control Studies; Coffee; Female; Huma | 2006 |
gamma-Radiation-induced chromosomal mutagen sensitivity is associated with breast cancer risk in African-American women: caffeine modulates the outcome of mutagen sensitivity assay.
Topics: Adult; Age Distribution; Aged; Aged, 80 and over; Biomarkers, Tumor; Black or African American; Brea | 2006 |
Health behaviors in breast cancer survivors experiencing bone loss.
Topics: Absorptiometry, Photon; Adult; Aged; Alcohol Drinking; Attitude to Health; Breast Neoplasms; Caffein | 2006 |
The CYP1A2 genotype modifies the association between coffee consumption and breast cancer risk among BRCA1 mutation carriers.
Topics: Adult; Breast Neoplasms; Caffeine; Canada; Case-Control Studies; Coffee; Confidence Intervals; Cytoc | 2007 |
Coffee, tea, caffeine and risk of breast cancer: a 22-year follow-up.
Topics: Adult; Aged; Body Mass Index; Breast Neoplasms; Caffeine; Central Nervous System Stimulants; Coffee; | 2008 |
Caffeine overcomes genistein-induced G2/M cell cycle arrest in breast cancer cells.
Topics: Antineoplastic Agents; Breast Neoplasms; Caffeine; Cell Line, Tumor; Dose-Response Relationship, Dru | 2008 |
Hormone and methylxanthine action on breast epithelial cells.
Topics: 2-Chloroadenosine; Adenosine; Animals; Breast; Breast Neoplasms; Caffeine; Cell Line; Cyclic AMP; Ep | 1984 |
Epidemiology and risk factors in breast cancer. Can we change the odds?
Topics: Adult; Breast Neoplasms; Caffeine; Diet; Female; Fibrocystic Breast Disease; Humans; Middle Aged; Ri | 1982 |
Alcohol, smoking, passive smoking and caffeine in relation to breast cancer risk in young women. UK National Case-Control Study Group.
Topics: Adolescent; Adult; Alcohol Drinking; Breast Neoplasms; Caffeine; Case-Control Studies; Chi-Square Di | 1994 |
No association between caffeine intake and postmenopausal breast cancer incidence in the Iowa Women's Health Study.
Topics: Aged; Breast Neoplasms; Caffeine; Chi-Square Distribution; Female; Humans; Incidence; Iowa; Middle A | 1993 |
Nutritional concerns of women with breast cancer.
Topics: Adult; Aged; Attitude to Health; Body Weight; Breast Neoplasms; Caffeine; Diet; Dietary Fats; Female | 1993 |
Hypothesis: coffee consumption, N-acetyltransferase phenotype, and cancer.
Topics: Acetylation; Arylamine N-Acetyltransferase; Breast Neoplasms; Caffeine; Coffee; Colonic Neoplasms; F | 1993 |
Paclitaxel-induced apoptosis in MCF-7 breast-cancer cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasm | 1997 |
Association of coffee, green tea, and caffeine intakes with serum concentrations of estradiol and sex hormone-binding globulin in premenopausal Japanese women.
Topics: Adult; Body Mass Index; Breast Neoplasms; Caffeine; Carbonated Beverages; Coffee; Estradiol; Female; | 1998 |
Coffee consumption and the risk of breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Caffeine; Carcinogens; Case-Control Studies; Coffee; Female; Humans; | 1998 |
Common fragile site expression and genetic predisposition to breast cancer.
Topics: Aphidicolin; Breast Neoplasms; Caffeine; Chromosome Aberrations; Chromosome Fragile Sites; Chromosom | 1998 |
Variation in sensitizing effect of caffeine in human tumour cell lines after gamma-irradiation.
Topics: Breast Neoplasms; Caffeine; Cell Cycle; Female; G1 Phase; G2 Phase; Gamma Rays; Humans; Radiation To | 2000 |
Structure-activity relationships for G2 checkpoint inhibition by caffeine analogs.
Topics: Breast Neoplasms; Caffeine; Cobalt Radioisotopes; DNA Damage; DNA Repair; G2 Phase; Humans; Structur | 2000 |
Cadmium induces phosphorylation of p53 at serine 15 in MCF-7 cells.
Topics: Androstadienes; Ataxia Telangiectasia Mutated Proteins; Breast Neoplasms; Cadmium Chloride; Caffeine | 2001 |
Coffee, tea, and caffeine consumption and breast cancer incidence in a cohort of Swedish women.
Topics: Adult; Aged; Breast Neoplasms; Caffeine; Coffee; Epidemiologic Methods; Female; Humans; Incidence; M | 2002 |
Caffeine eliminates gamma-ray-induced G2-phase delay in human tumor cells but not in normal cells.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzy | 2002 |
Breast cancer and methylxanthine consumption.
Topics: Adult; Aged; Beverages; Breast Neoplasms; Cacao; Caffeine; Candy; Carbonated Beverages; Case-Control | 1992 |
Methylxanthines and breast cancer.
Topics: Adult; Age Factors; Beverages; Breast Neoplasms; Cacao; Caffeine; Diagnosis-Related Groups; Epidemio | 1987 |
Methylxanthines and breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Caffeine; Diet; Female; Humans; Menopause; Middle Aged; Risk Factors; | 1988 |
Patient discomfort during screen-film mammography.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Caffeine; Female; Humans; Mammography; Menstruatio | 1988 |
Can a low-fat diet prevent breast cancer?
Topics: Breast Neoplasms; Caffeine; Dietary Fats; Female; Humans | 1987 |
Association of tumor differentiation with caffeine and coffee intake in women with breast cancer.
Topics: Breast Neoplasms; Caffeine; Cell Differentiation; Coffee; Female; Humans; Regression Analysis | 1986 |
Coffee and methylxanthines and breast cancer: a case-control study.
Topics: Adult; Breast Neoplasms; Caffeine; Coffee; Dietary Fats; Female; Humans; Middle Aged; Smoking; Xanth | 1985 |
Statistical errors invalidate conclusions in "Caffeine and unsaturated fat diet significantly promotes DMBA-induced breast cancer in rats".
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Breast Neoplasms; Caffeine; Cocarcinogenesis; Dietary Fat | 1985 |
Breast cancer and the consumption of coffee.
Topics: Adult; Age Factors; Aged; Breast Neoplasms; Caffeine; Coffee; Female; Fibrocystic Breast Disease; Hu | 1985 |